Pharma-Bio Serv (PBSV) Enterprise Value (2016 - 2026)
Pharma-Bio Serv (PBSV) has disclosed Enterprise Value for 15 consecutive years, with -$10.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 14.84% year-over-year to -$10.9 million, compared with a TTM value of -$10.9 million through Oct 2025, up 14.84%, and an annual FY2025 reading of -$10.9 million, up 14.84% over the prior year.
- Enterprise Value was -$10.9 million for Q4 2025 at Pharma-Bio Serv, down from -$10.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.4 million in Q2 2025 and bottomed at -$19.0 million in Q1 2021.
- Average Enterprise Value over 5 years is -$14.2 million, with a median of -$14.4 million recorded in 2022.
- The sharpest move saw Enterprise Value dropped 24.47% in 2021, then increased 22.75% in 2025.
- Year by year, Enterprise Value stood at -$17.5 million in 2021, then increased by 17.21% to -$14.5 million in 2022, then dropped by 3.56% to -$15.0 million in 2023, then increased by 14.9% to -$12.7 million in 2024, then rose by 14.84% to -$10.9 million in 2025.
- Business Quant data shows Enterprise Value for PBSV at -$10.9 million in Q4 2025, -$10.7 million in Q3 2025, and -$10.4 million in Q2 2025.